Literature DB >> 24726791

Acrylamide alters neurotransmitter induced calcium responses in murine ESC-derived and primary neurons.

Julia Sisnaiske1, Vanessa Hausherr2, Anne K Krug3, Bastian Zimmer4, Jan G Hengstler2, Marcel Leist3, Christoph van Thriel2.   

Abstract

Stem cell-derived specialized cell types are of interest as an alternative cell system to identify and research neurotoxic effects and modes of action. Developmental toxicity may be studied during differentiation, while organ-specific toxicity may be assessed in fully functional cells, such as neurons. In this study we tested if fully differentiated neurons derived from murine embryonic stem cells (ESCN) could be used to investigate the effects of the well characterized neurotoxic model compound acrylamide (ACR) and if ESCN behave similar to murine primary cortical neurons (pCN) from 16 days old embryos. We characterized the differentiation process of cryopreserved ESC-derived neural precursor cells (NPC) differentiating to ESCN. During the differentiation process (days 11-20) a strong increase in calcium responses to glutamate, acetylcholine and GABA were observed. Moreover, neuron specific marker proteins, β-III-tubulin, MAP2, Tau, Rbfox3 and synaptophysin showed similar patterns to pCN. In ESCN and pCN the neuronal structure, e.g. neurites, was not affected by low concentrations of ACR [0.5-1.6mM]. However, 24h incubation periods with 0.5-1.6mM ACR led to a reduction of acetylcholine and glutamate induced calcium responses. In conclusion, we show that non-cytotoxic concentrations of ACR alter neurotransmission in ESCN as well as pCN.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3R; Acrylamide; Neuronal function; Neurotoxicity testing; Stem cell

Mesh:

Substances:

Year:  2014        PMID: 24726791     DOI: 10.1016/j.neuro.2014.03.010

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  7 in total

1.  Aldose Reductase Regulates Microglia/Macrophages Polarization Through the cAMP Response Element-Binding Protein After Spinal Cord Injury in Mice.

Authors:  Qian Zhang; Ganlan Bian; Peng Chen; Ling Liu; Caiyong Yu; Fangfang Liu; Qian Xue; Sookja K Chung; Bing Song; Gong Ju; Jian Wang
Journal:  Mol Neurobiol       Date:  2014-12-19       Impact factor: 5.590

2.  Dietary acrylamide exposure was associated with mild cognition decline among non-smoking Chinese elderly men.

Authors:  Zhao-Min Liu; Lap Ah Tse; Bailing Chen; Suyang Wu; Dicken Chan; Timothy Kowk; Jean Woo; Yu-Tao Xiang; Samuel Yeung-Shan Wong
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

3.  Performance metrics of in vitro tests.

Authors:  Florian Seidel
Journal:  EXCLI J       Date:  2019-08-07       Impact factor: 4.068

4.  Stem cell-based test methods.

Authors:  Florian Seidel
Journal:  EXCLI J       Date:  2019-06-24       Impact factor: 4.068

5.  Transcriptome based differentiation of harmless, teratogenetic and cytotoxic concentration ranges of valproic acid.

Authors:  Regina Stöber
Journal:  EXCLI J       Date:  2014-12-11       Impact factor: 4.068

6.  Functional metabolic interactions of human neuron-astrocyte 3D in vitro networks.

Authors:  Daniel Simão; Ana P Terrasso; Ana P Teixeira; Catarina Brito; Ursula Sonnewald; Paula M Alves
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379

7.  Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests.

Authors:  Vaibhav Shinde; Lisa Hoelting; Sureshkumar Perumal Srinivasan; Johannes Meisig; Kesavan Meganathan; Smita Jagtap; Marianna Grinberg; Julia Liebing; Nils Bluethgen; Jörg Rahnenführer; Eugen Rempel; Regina Stoeber; Stefan Schildknecht; Sunniva Förster; Patricio Godoy; Christoph van Thriel; John Antonydas Gaspar; Jürgen Hescheler; Tanja Waldmann; Jan G Hengstler; Marcel Leist; Agapios Sachinidis
Journal:  Arch Toxicol       Date:  2016-05-17       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.